Overexpression of lncRNA UCA1 promotes osteosarcoma progression and correlates with poor prognosis

Journal of Bone Oncology

Volumn 5, Issue 2, 2016, Pages 80-85

  Li, Wei ^a   Xie, Peng ^a   Ruan, Wen Hui ^a  

^a Hanzhong Municipal Central Hospital   (China)

Author keywords

Invasion; LncRNA UCA1; Osteosarcoma; Prognosis

Indexed keywords

LONG UNTRANSLATED RNA; UCA1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CELL INVASION; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MIGRATION; OSTEOSARCOMA; OSTEOSARCOMA CELL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE;

EID: 84967214594     PISSN: 22121374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbo.2016.05.003     Document Type: Article

References (34)

1. D.S. Geller, and R. Gorlick Osteosarcoma: a review of diagnosis, management, and treatment strategies Clin. Adv. hematol. Oncol.: HO 8 10 2010 705 718
2. S.S. Bielack, B. Kempf-Bielack, G. Delling, G.U. Exner, S. Flege, K. Helmke, R. Kotz, M. Salzer-Kuntschik, M, Werner, W. Winkelmann, A. Zoubek, H. Jurgens, and K. Winkler Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols J. Clin. Oncol.: Official J. Am. Soc. Clin. Oncol. 20 3 2002 776 790
3. K. Eppert, J.S. Wunder, V. Aneliunas, R. Kandel, and I.L. Andrulis von Willebrand factor expression in osteosarcoma metastasis Modern Pathol.: an Official J. U. S. Can. Acad. Pathol. Inc 18 3 2005 388 397
4. P.A. Meyers Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma Expert Rev. anticancer Ther. 9 8 2009 1035 1049
5. K.C. Wang, and H.Y. Chang Molecular mechanisms of long noncoding RNAs Mol. Cell 43 6 2011 904 914
6. C. Ernst, and C.C. Morton Identification and function of long non-coding RNA, Front. Cell. Neurosci. 7 2013 168
7. A. Fatica, and I. Bozzoni Long non-coding RNAs: new players in cell differentiation and development Nat. Rev. Genet. 15 1 2014 7 21
8. T. Kunej, J. Obsteter, Z. Pogacar, S. Horvat, and G.A. Calin The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring Crit. Rev. Clin. Lab. Sci. 51 6 2014 344 357
9. P.G. Maass, F.C. Luft, and S. Bahring Long non-coding RNA in health and disease J. Mol. Med. 92 4 2014 337 346
10. A. Khandelwal, A. Bacolla, K.M. Vasquez, and A. Jain Long non-coding RNA: a new paradigm for lung cancer Mol. Carcinog. 54 11 2015 1235 1251
11. M. Cui, L. You, X. Ren, W. Zhao, Q. Liao, and Y. Zhao Long non-coding RNA PVT1 and cancer Biochem. Biophys. Res. Commun. 471 1 2016 10 14
12. J. Sun, X. Wang, C. Fu, X. Wang, J. Zou, H. Hua, and Z. Bi Long noncoding RNA FGFR3-AS1 promotes osteosarcoma growth through regulating its natural antisense transcript FGFR3 Mol. Biol. Rep. 2016
13. B. Ma, M. Li, L. Zhang, M. Huang, J.B. Lei, G.H. Fu, C.X. Liu, Q.W. Lai, Q.Q. Chen, and Y.L. Wang Upregulation of Long non-coding RNA TUG1 Correlates with poor prognosis and Disease Status in Osteosarcoma Tumour Biol.: J. Int. Soc. Oncodevelopmental Biol. Med. 2015
14. M. Cong, J. Li, R. Jing, and Z. Li Long non-coding RNA tumor suppressor Candidate 7 Functions as a tumor suppressor and Inhibits proliferation in Osteosarcoma Tumour Biol.: J. Int. Soc. Oncodevelopmental Biol. Med. 2016
15. C.L. Zhang, K.P. Zhu, G.Q. Shen, and Z.S. Zhu A Long non-coding RNA Contributes to Doxorubicin Resistance of Osteosarcoma Tumour Biol.: J. Int. Soc. Oncodevelopmental Biol. Med. 2015
16. F. Wang, X. Li, X. Xie, L. Zhao, and W. Chen UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion FEBS Lett. 582 13 2008 1919 1927
17. J.Y. Li, X. Ma, and C.B. Zhang Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma Int. J. Clin. Exp. Pathol. 7 11 2014 7938 7944
18. Y.L. Tuo, X.M. Li, and J. Luo Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143 Eur. Rev. Med. Pharmacol. Sci. 19 18 2015 3403 3411
19. W. Nie, H.J. Ge, X.Q. Yang, X. Sun, H. Huang, X. Tao, W.S. Chen, and B. Li LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p Cancer Lett. 371 1 2016 99 106
20. J. Gao, R. Cao, and H. Mu Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer Int. J. Clin. Exp. Pathol. 8 10 2015
21. Y. Han, Y.N. Yang, H.H. Yuan, T.T. Zhang, H. Sui, X.L. Wei, L. Liu, P. Huang, W.J. Zhang, and Y.X. Bai UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution Pathology 46 5 2014 396 401
22. F. Wang, H.Q. Ying, B.S. He, Y.Q. Pan, Q.W. Deng, H.L. Sun, J. Chen, X. Liu, and S.K. Wang Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway Oncotarget 6 10 2015 7899 7917
23. Y. Li, T. Wang, Y. Li, D. Chen, Z. Yu, L. Jin, L. Ni, S. Yang, X. Mao, Y. Gui, and Y. Lai Identification of Long-non coding RNA UCA1 as an Oncogene in Renal Cell Carcinoma Mol. Med. Rep. 2016
24. L. Zhang, X. Cao, L. Zhang, X. Zhang, H. Sheng, and K. Tao UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy Cancer Chemother. Pharmacol. 77 3 2016 629 634
25. X.Y. Na, Z.Y. Liu, P.P. Ren, R. Yu, and X.S. Shang Long non-coding RNA UCA1 contributes to the progression of prostate cancer and regulates proliferation through KLF4-KRT6/13 signaling pathway Int. J. Clin. Exp. Med. 8 8 2015 12609 12616
26. I. Dickson Hepatocellular carcinoma: A role for lncRNA in liver cancer Nat. Rev. Gastroenterol. Hepatol. 13 3 2016 122 123
27. M. Sun, F.Q. Nie, and Z.X. Wang W. De, Involvement of lncRNA dysregulation in gastric cancer Histol. Histopathol. 31 1 2016 33 39
28. Z. Bian, L. Jin, J. Zhang, Y. Yin, C. Quan, Y. Hu, Y. Feng, H. Liu, B. Fei, Y. Mao, L. Zhou, X. Qi, S. Huang, D. Hua, C. Xing, and Z. Huang LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p Sci. Rep. 6 2016 23892
29. S. Chen, C. Shao, M. Xu, J. Ji, Y. Xie, Y. Lei, and X. Wang Macrophage infiltration promotes invasiveness of breast cancer cells via activating long non-coding RNA UCA1 Int. J. Clin. Exp. Pathol. 8 8 2015 9052 9061
30. F. Wang, J. Zhou, X. Xie, J. Hu, L. Chen, Q. Hu, H. Guo, and C. Yu Involvement of SRPK1 in cisplatin resistance related to long non-coding RNA UCA1 in human ovarian cancer cells Neoplasma 2015
31. Y. Tian, X. Zhang, Y. Hao, Z. Fang, and Y. He Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma Melanoma Res. 24 4 2014 335 341
32. Y. Fan, B. Shen, M. Tan, X. Mu, Y. Qin, F. Zhang, and Y. Liu Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling FEBS J. 281 7 2014 1750 1758
33. Q. Zheng, F. Wu, W.Y. Dai, D.C. Zheng, C. Zheng, H. Ye, B. Zhou, J.J. Chen, and P. Chen Aberrant expression of UCA1 in gastric cancer and its clinical significance, Clinical and translational oncology: official publication of the Federation of Spanish Oncol. Soc. Natl. Cancer Inst. Mex. 17 8 2015 640 646
34. Y. Yang, Y. Jiang, Y. Wan, L. Zhang, J. Qiu, S. Zhou, and W. Cheng UCA1 Functions as a competing Endogenous RNA to Suppress epithelial Ovarian Cancer Metastasis Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med. 2016